Significant increase in volume has been observed in Concord Biotech Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Concord Biotech Limited has submitted their response.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech saw an unusually sharp rise in trading volume on the exchange. NSE reached out to the company to check whether there is any undisclosed information driving this activity. The company has submitted its response to the exchange, though the contents of that response are not detailed in this filing. This type of communication is routine when exchanges detect abnormal trading patterns. No specific corporate action or material event has been disclosed in this announcement.
Shareholders should look for the company's detailed response or any forthcoming disclosure to understand the reason behind the volume surge. Until then, the stock may remain volatile, and investors should watch for further announcements before making decisions.